ArtiFascia Pivotal NEOART study has been initiated

Nurami has announced the initiation of NEOART clinical study to test its Dural repair patch – ArtiFascia®. Multiple leading EU medical centers participate in the study. The enrollment of patients is ongoing.

https://clinicaltrials.gov/ct2/show/NCT04145544?term=artifascia&draw=2&rank=1

Share This Post

we want to hear from you

Skip to content